SWOG clinical trial number
SWOG-7208

5-Azacitidine (NSC-102816) Intravenously on five consecutive days every 3 weeks in Adults with Solid Tumors and Lymphomas

Closed
Phase
II
Abbreviated Title
5-Azacitidine (NSC-102816) Intravenously on five consecutive days every 3 weeks in Adults with Solid Tumors and Lymphomas
Activated
08/07/1972
Closed
10/16/1973

Publication Information Expand/Collapse

1978

Phase II study of 5-azacytidine in solid tumors.

JM Quagliana;RM O'Bryan;L Baker;J Gottlieb;FS Morrison;HJ Eyre;WB Tucker;J Costanzi Cancer Therapy Abstracts 2:4441

1977

Phase II study of 5-azacytidine in solid tumors.

JM Quagliana;RM O'Bryan;LH Baker;JE Gottlieb;FS Morrison;HJ Eyre;WG Tucker;JJ Costanzi Cancer Treat Rep 61:51-54

1974

A phase II study of 5-azacytidine (5-azaC) in the treatment of solid tumors.

JM Quagliana;JJ Costanzi;RM O'Bryan AACR 15:121 (#484)